Eikon Therapeutics, Inc. (EIKN)

Eikon Therapeutics will go public soon. The estimated IPO date is February 5, 2026.

IPO Price Range

$16.00 - $18.00

Shares Offered

17,648,000

Deal Size

$300.02M

Eikon Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Capitalization	858	-	-
Enterprise Value	729	-	-
Debt / Equity Ratio	-0.31	-0.35	-0.09
Debt / EBITDA Ratio	-0.81	-0.83	-0.12
Debt / FCF Ratio	-0.96	-0.92	-0.14
Quick Ratio	8.36	3.91	13.69
Return on Equity (ROE)	38.48%	42.63%	70.89%
Return on Assets (ROA)	-	-49.63%	-46.03%
Return on Capital Employed (ROCE)	720.06%	-59.88%	-53.76%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).